The global nasal drug delivery systems market size is
expected to reach USD 67.99 billion by 2025 expanding at 6.5% CAGR, according
to a new report by Grand View Research, Inc. Rising awareness about nasal
products is one of the major factors driving the market. Growing geriatric
population is also expected to have positive impact on the market. According to
the United Nations Department of Economic and Social Affairs, the global
geriatric population (60 years and above), was around 962 million in 2017. The
number is expected to grow, particularly in Latin America with 71% rise in
population aged 60 and over, followed by Asia (66%), Africa (64%), North
America (41%), and Europe (23%).
Moreover, ongoing product development and
their expected commercialization will propel market growth over the forecast period.
For instance, In April 2018, Dr. Reddy’s Laboratories, along with its
subsidiary Promius Pharma, LLC, announced filing of their New Drug Application
(NDA) for DFN-02, for the treatment of migraine. Increasing adoption of
self-administration practices and focus on other alternative routes of drug
delivery, such as nasal drug delivery, also offer growth opportunities for the
market. Some of the key companies in the industry are AstraZeneca PLC;
OptiNose, Inc.; Pfizer, Inc.; Becton, Dickinson and Company; Promius Pharma
LLC; B.F. Ascher & Company, Inc.; and Cadila Pharmaceuticals Ltd.
Browse full research report on Nasal
Drug Delivery Technology Market:
https://www.grandviewresearch.com/industry-analysis/nasal-drug-delivery-technology-system-market
Further key
findings from the study suggest:
- Nasal sprays led the dosage type segment in
2017 due to increased prevalence of asthma and other infectious diseases
- On the other hand, nasal drops segment
witnessed the fastest growth in 2017 owing to availability of
cost-effective products with better efficacy
- Non-pressurized containers segment led the
market in 2017 due to continous development in nasal powders and gel
products
- Asthma was the dominant therapeutic
application segment in 2017 and is estimated to be the fastest-growing
segment with a CAGR of 7.0% during the forecast years due to increasing
disease prevalence
- Geographically, North America held the largest
share in 2017. Asia Pacific is estimated to witness the fastest CAGR of
7.5% due to presence of key companies, such as Cipla Inc.
- Some of the leading companies in the global
nasal drug delivery technology market are GlaxoSmithKline PLC; AstraZeneca
PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and Company; Promius
Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher & Company, Inc.;
PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies Pty.
Ltd.; and NAVEH Pharma Ltd.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/nasal-drug-delivery-technology-system-market/request/rs1
Grand
View Research has segmented the global nasal drug delivery systems market
on the basis of dosage forms, container type, therapeutic application, and
region:
Nasal Drug
Delivery Systems Dosage Forms Outlook (Revenue, USD Billion, 2014 - 2025)
- Spray
- Drops
- Gel
- Powder
Nasal Drug
Delivery Systems Container Type Outlook (Revenue, USD Billion, 2014 -
2025)
- Pressurized
Container
- Non-pressurized
Container
Nasal Drug
Delivery Systems Therapeutic Application Outlook (Revenue, USD Billion,
2014 - 2025)
- Nasal Congestion
- Rhinitis
- Asthma
- Others
Nasal Drug
Delivery Systems Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East &
Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment